Ez-Grow

See table.

Excipients/Inactive Ingredients: Sorbitol (solvent) purified water (solvent), propylene glycol (solvent), orange oil flavor (flavoring), sucrose (sweetener), sodium citrate (buffering agent), citric acid (buffer solutions), sodium CMC (thickening agent), sodium benzoate (antimicrobial preservative), sodium saccharin (sweetening agent) and neohesperidine (flavoring enhancer/sweetening agent).

Prevention and therapy of damages due to faulty or deficient protein metabolism in chronic renal insufficiency in connection with limited protein in food of ≤40 g/day (for adults), ie generally in patients with a glomerular filtration rate (GFR) <25 mL/min.

Adults (70 kg body weight): Unless otherwise prescribed, take 4-8 tablets three times a day during meals. Swallow whole.

Ez-Grow is given as long as the GFR is <25 mL/min and a diet with an intake of maximum 40 g protein/day (for adults) is followed.

Hypercalcemia, disturbed amino acid metabolism. In case of hereditary phenylketonuria, it has to be taken into account that Ez-Grow contains phenylalanine.

The simultaneous administration of medicaments containing calcium (eg, acetolyte) may lead to pathological increases of the serum calcium level or intensification.

As the uremic symptoms improve under Ez-Grow, a possible administration of aluminum hydroxide should be reduced.

Pay attention to a reduction of serum phosphate.

In order not to interfere with absorption, do not take drugs together with Ez-Grow that form sparingly soluble compounds with calcium (eg, tetracyclines, quinolones eg, ciprofloxacin and norfloxacin, iron-, fluoride- and estramustin-containing drugs).

Between the intake of Ez-Grow and drugs from the mentioned categories, a period of at least 2 hrs should pass.

The susceptibility towards heart/cardiac-active glycosides and hence, also the risk of arrhythmia increases with the raise of the blood calcium concentration.

Diarrhea or constipation.